TAFINLAR
40 331,61 R$
Max. consumer price (CMED)
Analogs of TAFINLAR
Find cheaper analogs and generic equivalents for TAFINLAR.
Substanță activă: dabrafenib mesylate
Prezentare produs
About TAFINLAR
TAFINLAR is a medication containing the active ingredient dabrafenib mesylate, classified as Anti-cancer medication. Dabrafenib, sold under the brand name Tafinlar among others, is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the gene BRAF. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic.
- Use only as directed on the product label or by a healthcare professional.
- Follow the authorised product information for dosing and duration of use.
Active Ingredient & Action
dabrafenib mesylate, the active ingredient in TAFINLAR, belongs to the Anti-cancer medication class. 1 INDICATIONS AND USAGE TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test. ( 1. 1 , 2. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking TAFINLAR. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use TAFINLAR for extended periods without medical advice.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.